Navigation Links
Pittsburgh scientists identify human source of stem cells with potential to repair muscle
Date:9/4/2007

he Department of Pediatrics, Cell Biology and Physiology at the University of Pittsburgh School of Medicine, recognized the importance of determining the origin of these muscle-derived stem cells. His team applied, among others, techniques of confocal microscopy and cell sorting by flow cytometry which led to the discovery in human muscle biopsies that these myoendothelial cells are located adjacent to the walls of blood vessels.

According to their study, myoendothelial cells taken from the blood vessels are much more efficient at forming muscle than other sources of stem cells known as satellite and endothelial cells.

A thousand myoendothelial cells transplanted into the injured skeletal muscle of immunodeficient mice produced, on average, 89 muscle fibers, compared with 9 and 5 muscle fibers for endothelial and satellite cells, respectively. Myoendothelial cells also showed no propensity to form tumors, a concern with other stem cell therapies.

Drs. Huard, P ault and colleagues in Children's Stem Cell Research Center (SCRC) are researching and developing numerous therapeutic uses for the population of stem cells the SCRC team identified. One of the most promising uses could be for the treatment of DMD, a genetic disease estimated to affect one in every 3,500 boys. Patients with DMD lack dystrophin, a protein that gives muscle cells structure.

Dr. Huard is an internationally recognized cell biologist conducting laboratory research into the therapeutic use of stem cells to treat a variety of musculoskeletal and orthopaedic diseases and injuries. In the lab, Dr. Huard is developing cutting-edge therapies to regenerate bone and cartilage and to repair damaged muscle. The application of these therapies could range from the repair of heart muscle damaged by heart attack to the repair of sports-related bone, cartilage and muscle injuries.

Dr. Pault is internationally recognized principally for his work on the prospective
'/>"/>

Contact: Marc Lukasiak
marc.lukasiak@chp.edu
412-692-7919
Children's Hospital of Pittsburgh
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Roundup®highly lethal to amphibians, finds University of Pittsburgh researcher
2. Pittsburgh researchers discover that certain chemicals in the blood may indicate brain injury
3. Whats in the water? Estrogenic activity documented in fish caught in Pittsburghs rivers
4. The sturdier sex? -- Study by Pittsburgh scientists finds female stem cells work better
5. University of Pittsburgh School of Medicine researchers develop off-the-shelf vascular grafts
6. Wisconsin scientists grow critical nerve cells
7. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
8. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
9. UAB scientists discover the origin of a mysterious physical force
10. Fox Chase Cancer Center scientists identify immune-system mutation
11. Scientists Replicate Hepatitis C Virus in Laboratory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... likened to emptying a museum of its collection, or dumping ... replacing every local cuisine with McDonald,s burgers. , But the ... the world boring. New research now suggests it may also ... , "Habitat destruction and biodiversity loss,"driven by the replacement of ...
(Date:12/3/2009)... that staph infections are caused by many bacterial cells that ... called quorum sensing because many bacteria must be present to ... has determined that the very first stage of staph infection, ... occurs in a single cell and that this individual process ...
(Date:12/3/2009)... in the design of the upcoming forest deal at Copenhagen ... scientist at the University of Leeds. , Writing today ... least 50% of the carbon credit payments to be agreed ... Degredation), should be made to forest dwellers directly, and their ...
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Cancer Drugs Emerging as Top Driver of Specialty Drug Spending 5319 1Cancer Drugs Emerging as Top Driver of Specialty Drug Spending 5319 2Cancer Drugs Emerging as Top Driver of Specialty Drug Spending 5319 3Cancer Drugs Emerging as Top Driver of Specialty Drug Spending 5319 4Electronic Payment Exchange Welcomes New Visa Best Practices for Data Field Encryption 59123 1Electronic Payment Exchange Welcomes New Visa Best Practices for Data Field Encryption 59123 2Electronic Payment Exchange Welcomes New Visa Best Practices for Data Field Encryption 59123 3Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 14393 1Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 14393 2
... Distinct genetic profiles can discern different groups of ... which the body turns against itself, Dartmouth Medical ... subtypes within the disease offers new insight into ... to treat illness and opens a window for ...
... some northern tree species to disappear in the future, ... expand their range northward as soon as the conditions ... nearly so simple. A model developed by University of ... that while certain northern species, such as balsam fir, ...
... Johns Hopkins Kimmel Cancer Center researchers have identified ... with a deadly combination of,traditional mutations and "smothered" ... patients. , The Hopkins team showed that this ... of breast and colon,cancer by disrupting biochemical pathways ...
Other Biology News:Dartmouth researchers discover gene signatures for scleroderma 2Dartmouth researchers discover gene signatures for scleroderma 3Scattered nature of Wisconsin's woodlands could complicate forests' response to climate change 2'Smothered' genes combine with mutations to yield poor outcome in cancer patients 2
(Date:12/2/2009)... Reportlinker.com announces that a new market ... ,, Neurostimulation - A Global Market ... ,, The world neurostimulation market stands enthused ... and the resultant rise in age-related diseases ...
(Date:12/2/2009)... first concept demonstration tires made with BioIsoprene ... ingredient in the manufacture of synthetic rubber with renewable ... One tire will be on display at a lounge ... Airport throughout December 21, while the other tire will ...
(Date:12/2/2009)... Pepscan Holding NV,the Netherlands based biotechnology company focusing on ... announced that it,has appointed Wim E.M. Mol, Ph.D. as ... Dr. Mol will be responsible for all of Pepscans ... the company. He brings to,Pepscan more than 20 years ...
(Date:12/2/2009)... Inc.,("Emerald Dairy" or the "Company") (OTC Bulletin Board: EMDY), ... milk powder and,soybean products in China, today announced that ... US Food & Drink Executive, a quarterly magazine with ... beverage industry. , The article, ...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Dutch Biotech Company Pepscan Appoints New CEO 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2
... Luminex Corporation,(Nasdaq: LMNX ) today announced that ... Forum to be held October 9-11,2007, in San ... Balthrop, president and chief,executive officer, and Harriss T. ... Pacific time; 12:30 p.m. Eastern time on Thursday,October ...
... GENZ ) confirmed today that it will not change ... $5.60 in cash per,outstanding common share as set forth ... owns approximately 22 percent of the,outstanding shares of Bioenvision ... its preferred stock that carry a unique set of,rights ...
... Set for October, JACKSONVILLE, Fla., Sept. 27 ... "Company") announced today that its,performance/vitality beverage product, AQUISS(TM), ... California to the Oregon border. 7-Eleven,plans a launch ... an,aggressive sampling campaign to acquaint 7-Eleven,s customers with ...
Other Biology Technology:Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum 2Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share 2Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share 3Phlo Affiliate Reports AQUISS to be Sold in 450 7-Eleven Stores 2
Antibody Purification Specificity: Antibody Purification ...
... Conjugation Alkaline Phosphatase Conjugation ... Fluorescein Isothiocyanate Conjugation R. Phycoerythrin ... Alexa Fluor 488 Conjugation Alexa ... Conjugation Rpe-Alexa Fluor 750 Conjugation ...
Qa-1 (6A8.6F10)...
Human Cell Line Slides...
Biology Products: